BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

GeneQuantum and InxMed Partner for Innovative ADC Drug Research

According to the agreement, GeneQuantum will provide InxMed with its independently developed, globally leading technologies in site-specific glycan conjuga...

July 17, 2023 | News

Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma

XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...

July 17, 2023 | News

Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation

Fast Track Designation (FTD) aims to facilitate the development of drugs targeting severe or life-threatening diseases that have the potential to a...

July 12, 2023 | News

Transcenta Receives Approvals for Global Phase III Trial of Osemitamab (TST001)

To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...

July 10, 2023 | News

Hexvix® Completes Phase III Bridging Trial Enrollment for Bladder Cancer

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

July 10, 2023 | News

SK Bioscience and Government Pharmaceutical Organization Strengthen Vaccine Infrastructure in Thailand

SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...

July 05, 2023 | News

FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer

FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...

July 05, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

July 03, 2023 | News

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...

June 30, 2023 | News

Harbour BioMed's Batoclimab Receives NMPA Acceptance for Generalized Myasthenia Gravis Treatment

"Anti-FcRn treatment is at the center of focus in gMG disease area. Batoclimab is the first anti-FcRn treatment completed clinical development with po...

June 30, 2023 | News

Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D

This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...

June 29, 2023 | News

Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment

Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...

June 29, 2023 | News

AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine

After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...

June 28, 2023 | News

HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.

OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...

June 27, 2023 | News

Stay Connected